reglab/statecodes huggingface dataset:
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.01 - Public Swimming Pools and Spas › Section 10.17.01.54 - Compliance Schedules

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  owner of a public pool or spa that has a structure, equipment, or appurtenance
				  that is not in compliance with this chapter as determined by the Secretary may
				  submit to the Secretary for approval a compliance schedule for meeting the
				  requirements of this chapter.
B.
				  The request from an owner for approval of a compliance schedule shall include:
(1) The reason that the noncompliance item
				  cannot be immediately corrected;
(2) The plan for correction of the
				  noncompliance item; and
(3) The
				  time schedule for the correction of the noncompliance item.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.01 - Public Swimming Pools and Spas › Section 10.17.01.55 - Standardization and Audits of Local Health Departments

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Department shall:
(1) Standardize one employee related to the
				  enforcement of this chapter for each local health department to serve as the
				  local standardization officer;
(2)
				  Audit local health department pool and spa programs related to the enforcement
				  of this chapter once every 4 years according to the current audit protocols;
				  and
(3) Provide to the local health
				  department a pool and spa program review final report.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.02 - Vacant › Section 10.17.02.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter establishes guidelines for periodic
					 inspections and annual maintenance of the automated external defibrillators at
					 swimming pools.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.02 - Vacant › Section 10.17.02.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "AED" means automated external
				  defibrillator as defined in COMAR 30.06.01.01.
(2) "AED coordinator" means an individual
				  designated by the county or municipality to meet the requirement of COMAR
				  30.06.02.
(3) "Swimming pool" means
				  a pool that is owned and operated by the governing body of a county or
				  municipality.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.02 - Vacant › Section 10.17.02.03 - AED Program Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
Each county or municipality that owns and operates a
					 swimming pool shall develop and implement an automated external defibrillator
					 program that meets the requirements in the Education Article, §
										13-517, Annotated Code of
					 Maryland, and COMAR 30.06.02.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.02 - Vacant › Section 10.17.02.04 - Installation

Current through Register Vol. 51, No. 14, July 12, 2024
An AED shall be located within the pool barrier, as defined
					 in COMAR 10.17.01.05.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.02 - Vacant › Section 10.17.02.05 - Registration

Current through Register Vol. 51, No. 14, July 12, 2024
Each swimming pool owned and operated by a county or
					 municipality shall be registered as specified in COMAR 30.06.02.04.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.02 - Vacant › Section 10.17.02.06 - Training

Current through Register Vol. 51, No. 14, July 12, 2024
The AED coordinator shall ensure that at least one
					 individual who has a current AED certification from a national organization is
					 onsite while the swimming pool is open.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.02 - Vacant › Section 10.17.02.07 - Quality Assurance and Maintenance

Current through Register Vol. 51, No. 14, July 12, 2024
A county or municipality that owns and operates a swimming
					 pool shall:
A. Maintain the
				  certificate, equipment and supplies as required by COMAR 30.06.02;
				  and
B. Submit the reports as
				  required by COMAR 30.06.02 to the Maryland Institute for Emergency Medical
				  Services Systems (MIEMSS).
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 17 - SWIMMING POOLS AND SPAS › Chapter 10.17.02 - Vacant › Section 10.17.02.08 - Inspections

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Department
				  shall:
(1) Monitor a swimming pool for
				  compliance with this chapter; and
(2) Inspect the swimming pool as necessary
				  for the enforcement of this chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.01 - Maryland AIDS Drug Assistance Program: Temporary Assistance Program › Section 10.18.01.01 - Purpose

Current through Register Vol. 51, No. 14, July 12, 2024
The purpose of the Maryland AIDS Drug Assistance Program's
					 Temporary Assistance Program is to provide short term assistance to individuals
					 with Human Immunodeficiency Virus (HIV) who:
A. Need HIV drugs and other
				  products;
B. Have an application
				  for Medical Assistance or Low-Income Subsidy pending; and
C. Are considered likely to have their
				  application approved.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.01 - Maryland AIDS Drug Assistance Program: Temporary Assistance Program › Section 10.18.01.03 - Eligibility

Current through Register Vol. 51, No. 14, July 12, 2024
To be eligible for benefits, an individual shall meet the
					 following criteria:
A. Be a resident
				  of Maryland;
B. Be infected with
				  HIV; and
C. Have a pending
				  application to Medical Assistance or LIS.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.01 - Maryland AIDS Drug Assistance Program: Temporary Assistance Program › Section 10.18.01.04 - Application and Enrollment

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Application.
(1) The agent of the applicant
				  shall submit a completed TAP application to the Department on the form
				  designated by the Department that includes:
(a) Responses to all applicable questions;
				  and
(b) A copy of the completed
				  application or other verifiable documentation for Medical Assistance or LIS
				  enrollment.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.01 - Maryland AIDS Drug Assistance Program: Temporary Assistance Program › Section 10.18.01.05 - Covered Services

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  recipient shall obtain a prescription for each drug or other product ordered
				  for the recipient.
B. The
				  Department shall pay for a prescription drug or other product not excluded from
				  the open formulary if the prescription is ordered and signed by a health care
				  practitioner for a recipient.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.01 - Maryland AIDS Drug Assistance Program: Temporary Assistance Program › Section 10.18.01.06 - Recovery of Payments

Current through Register Vol. 51, No. 14, July 12, 2024
If benefits have been incorrectly paid or another payer has
					 been identified, the Department shall seek recovery of the amount of those
					 payments.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.01 - Maryland AIDS Drug Assistance Program: Temporary Assistance Program › Section 10.18.01.07 - Fraud

Current through Register Vol. 51, No. 14, July 12, 2024
The Department shall pursue cases of suspected
					 misrepresentation or fraud pursuant to Criminal Law Article, §
										8-503, Annotated Code of
					 Maryland, or any other applicable statutory provision.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.01 - Maryland AIDS Drug Assistance Program: Temporary Assistance Program › Section 10.18.01.08 - Confidentiality

Current through Register Vol. 51, No. 14, July 12, 2024
Except when communicating with the parties listed in
					 §B of this regulation and unless otherwise authorized by law, the agent of
					 an applicant, or the agent of a recipient, the Department:
A. Shall keep all applicant and recipient
				  personal information confidential;
B. May not disclose personal information kept
				  on an applicant or recipient without written consent of the:
(1) Applicant;
(2) Recipient;
(3) Applicant's parent or legal guardian;
				  or
(4) Recipient's parent or legal
				  guardian;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.01 - Maryland AIDS Drug Assistance Program: Temporary Assistance Program › Section 10.18.01.09 - Availability of Funding and Program Termination

Current through Register Vol. 51, No. 14, July 12, 2024
A. If sufficient monies are not available to
				  fund TAP, the Department shall take the action necessary to eliminate a deficit
				  which may include program termination.
B. If TAP is terminated, the Department shall
				  provide benefits for each current recipient in accordance with Regulation .04B
				  of this chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.02 - HIV and CD4+ Investigations and Case Reporting › Section 10.18.02.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
A. This chapter
				  establishes the requirements for:
(1)
				  Physician reporting of a:
(a) Case of human
				  immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS);
				  and
(b) Birth of an infant whose
				  mother has tested positive for HIV;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.02 - HIV and CD4+ Investigations and Case Reporting › Section 10.18.02.02 - Exemptions

Current through Register Vol. 51, No. 14, July 12, 2024
A. Qualifications
				  for Exemption. A research project that meets both of the following criteria may
				  be eligible for exemption from the HIV reporting requirements of Regulation .06
				  of this chapter:
(1) The research project has
				  been approved by an institutional review board; and
(2) The research:
(a) Is intended to determine the safety or
				  effectiveness of a vaccine that would produce immunity against HIV;
				  or
(b) Is not primarily intended to
				  provide medical treatment to participants.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.02 - HIV and CD4+ Investigations and Case Reporting › Section 10.18.02.04 - Physician Responsibility

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  physician shall:
(1) Report a case of HIV or
				  AIDS or newborn HIV exposure for a patient under the physician's care to the
				  health officer within 48 hours, by phone or in writing on a form provided by
				  the Secretary; and
(2) Include the
				  information requested on the form.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.02 - HIV and CD4+ Investigations and Case Reporting › Section 10.18.02.05 - Responsibilities of Clinical and Infection Control Practitioners in Institutions

Current through Register Vol. 51, No. 14, July 12, 2024
A. A clinical or
				  infection control practitioner working in an institution required to report as
				  set forth in Health-General Article, §18-202.1, Annotated Code of
				  Maryland, shall:
(1) Report a case of HIV or
				  AIDS under the care of the institution to the health officer within 48 hours,
				  by phone or in writing on a form provided by the Secretary; and
(2) Include the information requested on the
				  form.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.02 - HIV and CD4+ Investigations and Case Reporting › Section 10.18.02.06 - Responsibilities of Laboratory Directors

Current through Register Vol. 51, No. 14, July 12, 2024
A. Except as provided in Regulations .01C and
				  .02 of this chapter, the director of a medical laboratory shall:
(1) Submit a report to the health officer for
				  the jurisdiction where the laboratory is located, within 48 hours after an
				  examination of a specimen from a human body shows one of the following:
(a) A result on a test designed to detect in
				  a sample the presence of HIV in accordance with Health-General Article, §
				  18-207(b)(1), Annotated Code of Maryland, including negative results;
(b) A quantitative or qualitative HIV viral
				  load test result, including undetectable;
(c) A CD4+ cell test result, count, or
				  percentage in an individual not known to be HIV negative; or II
(d) An HIV genotype sequence test
				  result;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.02 - HIV and CD4+ Investigations and Case Reporting › Section 10.18.02.07 - Out-of-State Laboratories

Current through Register Vol. 51, No. 14, July 12, 2024
An out-of-State laboratory that holds a permit to operate
					 issued by Maryland and performs HIV detection, HIV viral load, CD4+ cell count
					 or percentage, or HIV genotype sequence tests shall submit the report required
					 under Regulation .06 of this chapter to the Secretary.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.02 - HIV and CD4+ Investigations and Case Reporting › Section 10.18.02.08 - Responsibility of Health Officer

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  This regulation establishes requirements for follow-up by the health officer of
				  a report of HIV or AIDS or newborn HIV exposure or laboratory report of HIV
				  detection, HIV viral load, CD4+ cell count or percentage, or HIV genotype
				  sequence.
B. This regulation does
				  not supplant or otherwise modify the:
(1)
				  Physician's obligation to report a case of HIV or AIDS or newborn HIV exposure
				  under Health-General Article, §18-201.1, Annotated Code of Maryland, and
				  Regulation .04 of this chapter;
(2)
				  Clinical or infection control practitioner's obligation to report a case of HIV
				  or AIDS under Health-General Article, §18-202.1, Annotated Code of
				  Maryland, and Regulation .05 of this chapter; and
(3) Laboratory director's obligation to
				  report a test result of HIV detection, HIV viral load, CD4+ cell count or
				  percentage, or HIV genotype sequence under Health-General Article, §
				  18-205, Annotated Code of Maryland, and Regulation .06 of this
				  chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.02 - HIV and CD4+ Investigations and Case Reporting › Section 10.18.02.09 - Record Maintenance and Confidentiality

Current through Register Vol. 51, No. 14, July 12, 2024
A. A person that submitted a report of HIV or
				  AIDS or newborn HIV exposure shall make available to the health officer or the
				  Secretary the information necessary to compile an HIV/AIDS case report,
				  according to Regulations .04-.06 of this chapter.
B. Except for a designated anonymous HIV test
				  site, a person that ordered the laboratory examination shall make available to
				  the health officer or the Secretary the information necessary to compile an
				  HIV/AIDS case report, according to Regulations .04 and .05 of this chapter,
				  upon receipt of one of the following:
(1) A
				  result on a test designed to detect in a sample the presence of HIV in
				  accordance with Health-General Article, § 18-207(b)(l), Annotated Code of
				  Maryland, including negative results;
(2) A qualitative or quantitative HIV viral
				  load test result, including undetectable;
(3) A CD4+ cell test result, count, or
				  percentage in an individual not known to be HIV negative; or
(4) An HIV genotype sequence test
				  result.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.03 - [Repealed] › Section 10.18.03.01

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.03 - [Repealed] › Section 10.18.03.02

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.03 - [Repealed] › Section 10.18.03.03

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.03 - [Repealed] › Section 10.18.03.04

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.03 - [Repealed] › Section 10.18.03.05

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Acquired Immunodeficiency Syndrome
				  (AIDS)" means the medical condition caused by the Human Immunodeficiency
				  Virus.
(2) "Applicant" means an
				  individual who has submitted an application to the Maryland AIDS Drug
				  Assistance Program and whose eligibility status for the Maryland AIDS Drug
				  Assistance Program has not yet been determined.
(3) "Department" means the Department of
				  Health and Mental Hygiene.
(4)
				  "Disenroll" means to end Maryland AIDS Drug Assistance Program
				  benefits.
(5) "Drug" means an
				  article intended for use in the diagnosis, cure, mitigation, treatment, or
				  prevention of disease licensed by the U.S. Food and Drug Administration and
				  covered by the Maryland AIDS Drug Assistance Program as specified in COMAR
				  10.18.06.04.
(6) "Enrolled in
				  MADAP" means that an applicant has been approved to receive Maryland AIDS Drug
				  Assistance Program benefits.
(7) "Gross household
				  income" means the income derived from sources provided in Regulation .02E of
				  this chapter.
(8) "Health care
				  practitioner" means any individual licensed to prescribe U.S. Food and Drug
				  Administration-approved drugs or other products in the state in which they
				  practice.
(9) "Human
				  Immunodeficiency Virus (HIV)" means the virus that causes AIDS.
(10) "Maryland AIDS Drug Assistance Program
				  (MADAP)" means the program administered by the Department that provides
				  services specified in COMAR
				  10.18.06.04 for enrolled
				  recipients.
(11) "Medical
				  Assistance" has the meaning stated in COMAR 10.09.24.02.
(12) "Open formulary" means all U.S. Food and
				  Drug Administration-approved prescription medications and related devices that
				  are not on the list of excluded drugs and other products maintained by the
				  Department according to COMAR
				  10.18.06.04-1.
(13) "Recipient" means an individual who is
				  enrolled in MADAP.
(14) "Resident"
				  means an individual:
(a) Who is living in the
				  State voluntarily with the intention of making it that individual's home and
				  not for a temporary purpose; and
(b) For whom any temporary absence from the
				  State is coupled with an intent to return so as not to interrupt the continuity
				  of the residence.
(15)
				  "Verification of eligibility" means the information a recipient provides to the
				  Department to confirm that the recipient is still eligible to receive MADAP
				  benefits according to Regulation .03B(1)(a) of this
				  chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.02 - Eligibility

Current through Register Vol. 51, No. 14, July 12, 2024
A. Except when an
				  individual is enrolled in Medical Assistance but does not have prescription
				  coverage assistance, an individual who is eligible for Medical Assistance is
				  not eligible for MADAP.
B. To be
				  eligible for benefits, an individual shall meet the following criteria:
(1) Residency;
(2) Medical; and
(3) Financial.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.03 - Application and Enrollment

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Application.
(1) Applicant.
(a) An applicant shall submit a completed
				  application to the Department on the form designated by the Department that
				  includes:
(i) Responses to all applicable
				  questions; and
(ii)  Supporting
				  documentation related to residency, medical, and financial eligibility
				  criteria.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.04 - Changes in Eligibility and Disenrollment

Current through Register Vol. 51, No. 14, July 12, 2024
A. A recipient shall notify the Department
				  within 10 business days of a change in:
(1)
				  Availability of third-party payment for services covered under MADAP;
(2) Gross household income; or
(3) Address.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.05 - Reconsideration and Appeal

Current through Register Vol. 51, No. 14, July 12, 2024
A. An
				  applicant or recipient who has been notified by the Department of ineligibility
				  for or disenrollment from MADAP benefits may request reconsideration of the
				  decision by submitting additional supporting documentation or information to
				  the Department within 30 business days of notification.
B. If an applicant or recipient submits a
				  timely request for reconsideration, the Department shall:
(1) Review all additional supporting
				  documentation, within 5 business days of the Department's receipt of the
				  request for reconsideration; and
(2) Issue a final decision in writing to the
				  applicant or recipient.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.06 - Recovery of Payments

Current through Register Vol. 51, No. 14, July 12, 2024
If MADAP benefits have been incorrectly paid or another
					 payer has been identified, the Department shall seek recovery of the amount of
					 those payments.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.07 - Fraud

Current through Register Vol. 51, No. 14, July 12, 2024
The Department shall pursue cases of suspected
					 misrepresentation or fraud pursuant to Criminal Law Article, §
										8-503, Annotated Code of
					 Maryland, or any other applicable statutory provision.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.08 - Confidentiality

Current through Register Vol. 51, No. 14, July 12, 2024
Unless otherwise authorized by law, the Department:
A. Shall keep all applicant and recipient
				  personal information confidential;
B. May not disclose personal information kept
				  on an applicant or recipient without written consent of the:
(1) Applicant;
(2) Recipient;
(3) Applicant's parent or legal guardian;
				  or
(4) Recipient's parent or legal
				  guardian;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.09 - Availability of Funding and Program Termination

Current through Register Vol. 51, No. 14, July 12, 2024
A. If sufficient monies are not available to
				  fund MADAP, the Department shall take the action necessary to eliminate a
				  deficit which may include MADAP termination.
B. If MADAP is terminated the Department
				  shall provide benefits for each current recipient until the earlier of:
(1) The date on which the next verification
				  of eligibility is due to be submitted to the Department; or
(2) Six months from the date MADAP is
				  terminated.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.10 - Repealed

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.11 - Repealed

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.12 - Repealed

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.13 - Repealed

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.14 - Repealed

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.05 - Maryland AIDS Drug Assistance Program: Eligibility › Section 10.18.05.15 - Repealed

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Acquired Immunodeficiency Syndrome
				  (AIDS)" means the medical condition caused by the Human Immunodeficiency
				  Virus.
(2) "Department" means the
				  Department of Health and Mental Hygiene.
(3) "Drug" means an article intended for use
				  in the diagnosis, cure, mitigation, treatment, or prevention of disease
				  licensed by the U.S. Food and Drug Administration and covered by the Maryland
				  AIDS Drug Assistance Program as specified in Regulation .04 of this
				  chapter.
(4) "Enrolled in MADAP"
				  means that an applicant has been approved to receive Maryland AIDS Drug
				  Assistance Program benefits.
(5)
				  "Health care practitioner" means any individual licensed to prescribe U.S. Food
				  and Drug Administration-approved drugs or other products in the state in which
				  they practice.
(6) "Human
				  Immunodeficiency Virus (HIV)" means the virus that causes AIDS.
(7) "Maryland AIDS Drug Assistance Program
				  (MADAP)" means the program administered by the Department that provides
				  services specified in Regulation .04 of this chapter for enrolled
				  recipients.
(8) "Medical
				  Assistance" has the meaning stated in COMAR 10.09.24.02.
(9) "Open formulary" means all U.S. Food and
				  Drug Administration-approved prescription medications and related devices that
				  are not on the list of excluded drugs and other products maintained by the
				  Department according to Regulation .04-1 of this chapter.
(10) "Pharmacist" means an individual
				  registered and licensed to practice pharmacy in the state where the
				  prescription is filled.
(11)
				  "Pharmacy" means an establishment or institution registered and licensed to
				  dispense U.S. Food and Drug Administration-approved drugs or other products to
				  the public in the state in which the establishment or institution is
				  located.
(12) "Preauthorization"
				  means an approval required before the dispensing of the prescription.
(13) "Prescription" means a direction,
				  usually written by a health care provider authorized to prescribe drugs and
				  other products and sent to the pharmacist for the preparation, dispensing, and
				  directions for use of a drug or other product not excluded from the open
				  formulary.
(14) "Recipient" means
				  an individual who is enrolled in MADAP.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.02 - License Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
The license requirements for participation in MADAP are the
					 same as those for the Medical Assistance Pharmacy Services Program set forth at
					 COMAR 10.09.03.02H.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.03 - Conditions for Participation

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  To participate in MADAP, a pharmacy shall:
(1) Be enrolled in Medical Assistance, be a
				  mail order company that accepts payments from the Department, or submit a
				  request for exception to, and receive approval from, the Department;
(2) Accept payment by the Department as
				  payment in full for the professional services rendered and make no additional
				  charges to the recipient or the recipient's family;
(3) Maintain records in accordance with
				  standards established by Medical Assistance;
(4) Maintain prescriptions for a minimum of 5
				  years and make them available for inspection, upon request, to the Department
				  or its designee;
(5) Provide services without regard to race, color,
				  creed, age, sex, sexual orientation, gender identity, national origin, marital
				  status, or disability; and
(6) Bill the recipient's third-party
				  insurance payer in accordance with the payer's requirements in order to reduce
				  the cost to be paid by the Department.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.04 - Covered Services

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  recipient shall obtain a prescription for each drug or other product ordered
				  for the recipient.
B. The
				  Department shall pay for a prescription drug or other product not excluded from
				  the open formulary if the prescription is ordered and signed by a health care
				  practitioner for the recipient.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.04-1 - Formulary

Current through Register Vol. 51, No. 14, July 12, 2024
The Department shall:
A. Maintain a list of drugs and other
				  products excluded from the open formulary; and
B. Make available electronically the list of
				  drugs and other products excluded from the open formulary.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.04-2

Current through Register Vol. 51, No. 14, July 12, 2024
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.05 - Limitations on Covered Services

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  A pharmacist may not dispense more than a 100-day supply of a prescribed drug
				  or other product.
B. The Department
				  may not pay for:
(1) A drug or other product
				  prescribed as part of a recipient's care in a correctional institution,
				  inpatient hospital, nursing home, or long-term care setting; or
(2) Drugs or other products excluded from the
				  open formulary, unless the:
(a) Recipient has
				  submitted the completed preauthorization request form to the Department;
				  and
(b) The Department has approved
				  the request.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.06 - Preauthorization Requirement

Current through Register Vol. 51, No. 14, July 12, 2024
A pharmacist shall obtain preauthorization for each
					 prescription or refill before dispensing a drug or other product marked as
					 restricted.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.07 - Payment Procedures

Current through Register Vol. 51, No. 14, July 12, 2024
A. Except
				  as provided in §§B and C of this regulation, the Department shall pay
				  a pharmacy in accordance with the procedures of the Medical Assistance Pharmacy
				  Services Program set forth at COMAR 10.09.03.07.
B. If the Department or the recipient tells
				  the pharmacy that the recipient has or may have third-party insurance coverage
				  to offset some or all of the cost for services provided under MADAP, the
				  pharmacy shall:
(1) Bill the third-party payer
				  the pharmacy's usual and customary charge for the services provided; and
(2) Bill the Department for the
				  difference between the pharmacy's usual and customary charge and the
				  anticipated third-party receipts.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.08 - Recovery and Reimbursement

Current through Register Vol. 51, No. 14, July 12, 2024
The Department shall follow the same procedures for
					 recovery and reimbursement as the Medical Assistance Pharmacy Services Program
					 in COMAR 10.09.03.08F.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.09 - Cause lor Suspension or Removal and Imposition of Sanctions

Current through Register Vol. 51, No. 14, July 12, 2024
A. If the
				  Department determines that a pharmacy or the pharmacy's employee, or both, has
				  failed to comply with federal or State laws and regulations, the Department
				  may:
(1) Suspend the pharmacy from
				  MADAP;
(2) Withhold payment to the
				  pharmacy; or
(3) Both.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.10 - Appeal Procedures

Current through Register Vol. 51, No. 14, July 12, 2024
A pharmacy filing an appeal shall do so in accordance with
					 the Medical Assistance Pharmacy Services Program as set forth at COMAR
					 10.09.03.10.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.11 - Confidentiality

Current through Register Vol. 51, No. 14, July 12, 2024
Unless otherwise authorized by law, the Department:
A. Shall keep all applicant and recipient
				  personal information confidential;
B. May not disclose personal information kept
				  on a recipient without written consent of the:
(1)
				  Recipient; or
(2) Recipient's parent
				  or legal guardian;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.06 - Maryland AIDS Drug Assistance Program: Pharmacy Services › Section 10.18.06.12 - Availability of Funding and Program Termination

Current through Register Vol. 51, No. 14, July 12, 2024
A. If sufficient monies are not available to
				  fund MADAP, the Department shall take the action necessary to eliminate a
				  deficit which may include MADAP termination.
B. If MADAP is terminated, the Department
				  shall provide benefits for each current recipient in accordance with COMAR
				  10.18.05.09B.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.07 - Maryland AIDS Drug Assistance Program: Health Insurance (MADAP-PLUS) › Section 10.18.07.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this chapter,
				  the following terms have the meanings indicated.
B. Terms Defined.
(1) "Acquired Immunodeficiency Syndrome
				  (AIDS)" means the medical condition caused by the Human Immunodeficiency
				  Virus.
(2) "Applicant" means an
				  individual who has submitted an application to the Maryland AIDS Drug
				  Assistance Program-Plus and whose eligibility status for the Maryland AIDS Drug
				  Assistance Program-Plus has not yet determined.
(3) "Core medical services" means a set of
				  direct health care services as specified by the Ryan White Care Act Part B
				  Program administered by the U.S. Health Resource and Services
				  Administration.
(4) "Department"
				  means the Department of Health and Mental Hygiene.
(5) "Enrolled in MADAP" means that an
				  applicant has been approved to receive Maryland AIDS Drug Assistance Program
				  benefits.
(6) "Health care
				  provider" means an individual licensed to provide core medical services in the
				  state where services are rendered.
(7) "Human immunodeficiency virus (HIV)"
				  means the virus that causes AIDS.
(8) "Maryland AIDS Drug Assistance Program
				  (MADAP)" means the program administered by the Department that provides
				  services specified in COMAR
				  10.18.06.04 for enrolled
				  recipients.
(9) "Maryland AIDS Drug Assistance Program-Plus
				  (MADAP-Plus)" means the program administered by the Department to pay insurance
				  premiums, copays, coinsurance, and deductibles for drugs and core medical
				  services.
(10) "Medical Assistance"
				  has the meaning stated in COMAR 10.09.24.02.
(11) "Open formulary" means all U.S. Food and
				  Drug Administration-approved prescription medications and related devices that
				  are not on the list of excluded drugs and other products maintained by the
				  Department according to COMAR
				  10.18.06.04-1.
(12) "Recipient" means an individual who is
				  enrolled in MADAP-Plus.
(13)
				  "Verification of eligibility" means the information a recipient provides to the
				  Department to confirm that the recipient is still eligible to receive MADAP
				  benefits according to COMAR
				  10.18.05.03B(1)(a).
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.07 - Maryland AIDS Drug Assistance Program: Health Insurance (MADAP-PLUS) › Section 10.18.07.02 - Eligibility

Current through Register Vol. 51, No. 14, July 12, 2024
A. To be eligible
				  for MADAP-Plus coverage, an individual shall be:
(1) Enrolled in MADAP; and
(2) Receiving or eligible to receive health
				  insurance and prescription drug coverage.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.07 - Maryland AIDS Drug Assistance Program: Health Insurance (MADAP-PLUS) › Section 10.18.07.03 - Application and Enrollment

Current through Register Vol. 51, No. 14, July 12, 2024
A. An
				  applicant shall apply in the manner set forth in COMAR
				  10.18.05.03A.
B. A recipient and the Department
				  shall meet the enrollment responsibilities set forth in COMAR
				  10.18.05.03B.
C. The duration of the recipient's
				  enrollment in MADAP-Plus may not extend beyond the duration of the recipient's
				  enrollment in MADAP.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.07 - Maryland AIDS Drug Assistance Program: Health Insurance (MADAP-PLUS) › Section 10.18.07.04 - Covered Services

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  Department shall pay for health and prescription plan premiums with a
				  prescription drug formulary that includes antiretroviral medications.
B. Within the limits established by the
				  Department and in accordance with policy guidance issued by the Health
				  Resources and Services Administration, the Department:
(1) Shall pay for copays, coinsurance, and
				  deductibles for drugs; and
(2) May
				  pay for copays, coinsurance, and deductibles associated with core medical
				  services.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 3 › Subtitle 18 - HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) › Chapter 10.18.07 - Maryland AIDS Drug Assistance Program: Health Insurance (MADAP-PLUS) › Section 10.18.07.05 - Changes in Eligibility and Disenrollment

Current through Register Vol. 51, No. 14, July 12, 2024
A. A recipient shall inform the Department of
				  a change in eligibility as set forth in COMAR
				  10.18.05.04A.
B. If a change reported in §A
				  of this regulation results in a recipient no longer qualifying for MADAP-Plus,
				  the Department shall:
(1) Determine the
				  recipient ineligible for MADAP-Plus; and
(2) Disenroll the recipient.